Purchase Order HHSN275201600311P
- Not listed
- This firm fixed-price purchase order, valued at $14,607.70, was awarded by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc. for gene synthesis and cloning services. The ultimate completion date is August 29, 2024. Genscript is a biotechnology company based in Piscataway, New Jersey that specializes in molecular biology products and services to support biomedical research and public health initiatives for various federal agencies, including the National...
- This federal contract award, valued at $24,999.00, was issued by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in New Jersey. The contract requires Genscript to generate four stable cell lines, with a final completion date of March 11, 2022. This was a firm fixed-price purchase order, and there was no set-aside designation. Genscript has received...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,982.04 contract is for the provision of customized protein services, gene synthesis, and other molecular biology products and services to support biomedical research and public health initiatives. The contract does not...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a small business biotechnology company based in Piscataway, New Jersey, for $11,434.95. The contract has an ultimate completion date of July 30, 2025. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other...
- This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, is for the provision of a wide range of molecular biology products and services to support biomedical research and public health initiatives. The $19,395.39 firm fixed-price purchase order contract, awarded by the National Institute of Child Health and Human Development (NICHD), covers gene synthesis, cloning, protein expression and purification, antibody production, and other...
- This is a $14,500 firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for NICHD laboratory services and does not have a set-aside designation. Genscript is a provider of a wide range of molecular biology products and services to federal agencies, including gene...
- This federal contract award was made by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,385.32 firm fixed-price purchase order is for gene synthesis services to support NICHD's research activities. The contract does not have a set-aside designation. Genscript USA Inc. is a for-profit organization that has...
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
- This is a $10,594.44 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey, without a set-aside designation. The contract requires Genscript to provide a range of molecular biology products and services, including gene synthesis, gene...
- This federal contract award, valued at $4,367.10, was issued by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for a firm fixed-price purchase order with a completion date of September 30, 2014. Genscript, which operates as a for-profit organization, has received numerous prime and subcontract awards from various Department of Health and Human Services (HHS) agencies, including...
This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $21,277.24, is for the generation of a POLH/POLI knockout MRC5SV cell line and other associated services. The contract does not have a set-aside designation. Genscript is a well-established provider of molecular biology products and services to various federal agencies, including NIH, CDC, FDA, and USDA. Through this and other contracts, the company has supported a wide range of biomedical research and public health initiatives, such as vaccine development, therapeutic antibody research, and diagnostic assay creation. The company currently holds a significant $1.5 million blanket purchase agreement with USDA's Animal and Plant Health Inspection Service (APHIS) to provide SARS-CoV-2 surrogate virus neutralization test kits and associated reagents.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($1) | 5/13/21 | |
| Not listed | Not listed | $21.3k | 4/13/16 |